• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

动态对比增强磁共振成像作为膀胱癌肿瘤血管生成评估的诊断工具。

Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a Diagnostic Tool in the Assessment of Tumour Angiogenesis in Urinary Bladder Cancer.

机构信息

Faculty of Medicine, Tanta University, Tanta, Gharbia Governorate, Egypt.

Diagnostic Radiology Department, Urology and Nephrology Center, Mansoura University, Mansoura, Dakahlia Governorate, Egypt.

出版信息

Can Assoc Radiol J. 2019 Aug;70(3):254-263. doi: 10.1016/j.carj.2018.11.004. Epub 2019 Mar 25.

DOI:10.1016/j.carj.2018.11.004
PMID:30922786
Abstract

PURPOSE

The aim of study is to assess the role of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and correlation with tumour angiogenesis in evaluation of urinary bladder cancer.

MATERIAL AND METHODS

The study included 81 patients with recent presumed diagnosis of bladder tumour or who came for follow up after management of histopathologically proven bladder cancer. All had DCE-MRI with time-signal intensity curve. The radiologic results then correlated with the histopathologic results using both haematoxylin and eosin stain and immuno-histochemical staining for localization and evaluation of CD34 immunoreactivity as a detector for the microvessel density (MVD) and tumour angiogenesis.

RESULTS

Seventy-one cases were pathologically proven to be malignant: 41 cases (58%) showed type III time-signal intensity curve (descending); 22 cases (31%) showed type II (plateau); and 8 cases (11%) showed type I (ascending) curve. The sensitivity of DCE-MRI in stage T1 bladder tumour was 80%; in stage T2, it was (90.9%); and in stage T3, it was (96.9%). Overall accuracy of DCE-MRI in tumour staging was 89.5% and P = .001 (significant). Values more than the cutoff value = 76.13 MVD are cystitis with sensitivity (90%), specificity (91%), and P value is .001, which is statistically highly significant.

CONCLUSION

There is a strong positive association between DCE-MRI (staging and washout slope of the time-signal intensity curve) with histopathologic grade, tumour stage, and MVD in bladder cancer. So, DCE-MRI can be used as reliable technique in preoperative predictions of tumour behavior and affect the planning of antiangiogenetic therapy.

摘要

目的

本研究旨在评估动态对比增强磁共振成像(DCE-MRI)在膀胱癌评估中的作用及其与肿瘤血管生成的相关性。

材料和方法

本研究纳入了 81 例近期疑似膀胱癌患者或经组织病理学证实的膀胱癌治疗后随访患者。所有患者均行 DCE-MRI 检查,并绘制时间-信号强度曲线。然后,使用苏木精和伊红染色以及免疫组织化学染色,对放射学结果与组织病理学结果进行相关性分析,以定位和评估 CD34 免疫反应性,作为微血管密度(MVD)和肿瘤血管生成的检测指标。

结果

71 例患者的病理结果证实为恶性肿瘤:41 例(58%)表现为 III 型时间-信号强度曲线(下降型);22 例(31%)表现为 II 型(平台型);8 例(11%)表现为 I 型(上升型)曲线。DCE-MRI 在 T1 期膀胱癌中的敏感度为 80%;在 T2 期为 90.9%;在 T3 期为 96.9%。DCE-MRI 对肿瘤分期的总体准确率为 89.5%,P 值为.001(具有统计学意义)。超过截断值(=76.13 MVD)的值与膀胱炎的敏感度(90%)、特异性(91%)相关,P 值为.001,具有统计学显著意义。

结论

DCE-MRI(分期和时间-信号强度曲线的洗脱斜率)与膀胱癌的组织病理学分级、肿瘤分期和 MVD 之间存在强烈的正相关关系。因此,DCE-MRI 可作为术前预测肿瘤行为的可靠技术,并影响抗血管生成治疗的规划。

相似文献

1
Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a Diagnostic Tool in the Assessment of Tumour Angiogenesis in Urinary Bladder Cancer.动态对比增强磁共振成像作为膀胱癌肿瘤血管生成评估的诊断工具。
Can Assoc Radiol J. 2019 Aug;70(3):254-263. doi: 10.1016/j.carj.2018.11.004. Epub 2019 Mar 25.
2
Value of dynamic contrast-enhanced MRI and correlation with tumor angiogenesis in bladder cancer.动态对比增强磁共振成像在膀胱癌中的价值及其与肿瘤血管生成的相关性
AJR Am J Roentgenol. 2009 Apr;192(4):949-55. doi: 10.2214/AJR.08.1332.
3
Three-dimensional contrast enhanced ultrasound score and dynamic contrast-enhanced magnetic resonance imaging score in evaluating breast tumor angiogenesis: correlation with biological factors.三维对比增强超声评分与动态对比增强磁共振成像评分在评估乳腺肿瘤血管生成中的应用:与生物学因素的相关性
Eur J Radiol. 2014 Jul;83(7):1098-1105. doi: 10.1016/j.ejrad.2014.03.027. Epub 2014 Apr 12.
4
Combining dynamic contrast enhanced magnetic resonance imaging and microvessel density to assess the angiogenesis after PEI in a rabbit VX2 liver tumor model.在兔VX2肝肿瘤模型中,联合动态对比增强磁共振成像和微血管密度评估经皮乙醇注射后血管生成情况。
Magn Reson Imaging. 2016 Feb;34(2):177-82. doi: 10.1016/j.mri.2015.10.013. Epub 2015 Oct 27.
5
Contrast-Enhanced Ultrasound Differentiation Between Low- and High- Grade Bladder Urothelial Carcinoma and Correlation With Tumor Microvessel Density.对比增强超声鉴别低级别和高级别膀胱尿路上皮癌及其与肿瘤微血管密度的相关性
J Ultrasound Med. 2017 Nov;36(11):2287-2297. doi: 10.1002/jum.14262. Epub 2017 May 27.
6
Improving bladder cancer imaging using 3-T functional dynamic contrast-enhanced magnetic resonance imaging.使用3-T功能动态对比增强磁共振成像改善膀胱癌成像
Invest Radiol. 2014 Jun;49(6):390-5. doi: 10.1097/RLI.0000000000000022.
7
Contrast-enhanced dynamic and diffusion-weighted MR imaging at 3.0T to assess aggressiveness of bladder cancer.在3.0T磁场下进行对比增强动态磁共振成像和扩散加权磁共振成像以评估膀胱癌的侵袭性。
Eur J Radiol. 2014 Nov;83(11):2013-8. doi: 10.1016/j.ejrad.2014.08.012. Epub 2014 Aug 29.
8
Update on multiparametric MRI of urinary bladder cancer.膀胱癌多参数 MRI 研究进展。
J Magn Reson Imaging. 2018 Oct;48(4):882-896. doi: 10.1002/jmri.26294. Epub 2018 Sep 17.
9
Bladder transitional cell carcinoma: correlation of contrast enhancement on computed tomography with histological grade and tumour angiogenesis.膀胱移行细胞癌:计算机断层扫描对比增强与组织学分级及肿瘤血管生成的相关性
Clin Radiol. 2005 Feb;60(2):215-23. doi: 10.1016/j.crad.2004.05.009.
10
Multiparametric 3-T MRI for differentiating low-versus high-grade and category T1 versus T2 bladder urothelial carcinoma.多参数3-T磁共振成像用于鉴别低级别与高级别以及T1期与T2期膀胱尿路上皮癌
AJR Am J Roentgenol. 2015 Feb;204(2):330-4. doi: 10.2214/AJR.14.13147.

引用本文的文献

1
Multiparametric MRI Features of Plasmacytoid Urothelial Carcinoma of the Urinary Bladder.膀胱浆细胞样尿路上皮癌的多参数磁共振成像特征
Korean J Radiol. 2025 Sep;26(9):832-840. doi: 10.3348/kjr.2025.0419.
2
Predictive Potential of Contrast-Enhanced MRI-Based Delta-Radiomics for Chemoradiation Responsiveness in Muscle-Invasive Bladder Cancer.基于对比增强MRI的Delta放射组学对肌层浸润性膀胱癌放化疗反应的预测潜力
Diagnostics (Basel). 2025 Mar 21;15(7):801. doi: 10.3390/diagnostics15070801.
3
Precise vesical wall staging of bladder cancer in the era of precision medicine: has it been fulfilled?
精准医学时代膀胱癌的膀胱壁精确分期:是否已经实现?
Abdom Radiol (NY). 2024 Dec 27. doi: 10.1007/s00261-024-04786-8.
4
An Overview of Angiogenesis in Bladder Cancer.膀胱癌中的血管生成概述。
Curr Oncol Rep. 2023 Jul;25(7):709-728. doi: 10.1007/s11912-023-01421-5. Epub 2023 Apr 13.
5
Recent Developments in Imaging in BPS/IC.膀胱疼痛综合征/间质性膀胱炎的影像学最新进展
Curr Bladder Dysfunct Rep. 2019 Dec;14(4):301-307. doi: 10.1007/s11884-019-00556-1. Epub 2019 Dec 14.
6
Comparison of the diagnostic accuracy and validity of biparametric MRI and multiparametric MRI-based VI-RADS scoring in bladder cancer; is contrast material really necessary in detecting muscle invasion?基于 biparametric MRI 和 multiparametric MRI-based VI-RADS 评分的膀胱癌诊断准确性和有效性比较;在检测肌肉侵犯时,造影剂真的有必要吗?
Abdom Radiol (NY). 2022 Feb;47(2):771-780. doi: 10.1007/s00261-021-03383-3. Epub 2021 Dec 17.
7
Study Progress of Noninvasive Imaging and Radiomics for Decoding the Phenotypes and Recurrence Risk of Bladder Cancer.用于解码膀胱癌表型和复发风险的非侵入性成像及放射组学研究进展
Front Oncol. 2021 Jul 15;11:704039. doi: 10.3389/fonc.2021.704039. eCollection 2021.
8
[Advances in magnetic resonance imaging guided radiation therapy].[磁共振成像引导放射治疗的进展]
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2021 Feb 25;38(1):161-168. doi: 10.7507/1001-5515.202002029.
9
Imaging of Bladder Cancer: Standard Applications and Future Trends.膀胱癌的影像学检查:标准应用与未来趋势
Medicina (Kaunas). 2021 Mar 1;57(3):220. doi: 10.3390/medicina57030220.
10
Bladder cancer: do we need contrast injection for MRI assessment of muscle invasion? A prospective multi-reader VI-RADS approach.膀胱癌:MRI评估肌肉浸润是否需要注射造影剂?一项前瞻性多阅片者VI-RADS研究方法
Eur Radiol. 2021 Jun;31(6):3874-3883. doi: 10.1007/s00330-020-07473-6. Epub 2020 Nov 19.